The COVID-19 pandemic threatens to reverse recent progress in reducing the global burden of tuberculosis. The global number of deaths for tuberculosis could increase by around 200.000–400.000 in 2020 alone, as result of essential tuberculosis services disruptions due to the reallocation of human, financial and other resources from tuberculosis to the COVID-19 response, as reported by WHO: https://bit.ly/35KyzD
The impact of Covid-19 in Africa is a ticking bomb on which the European Union (EDCTP) intervenes by supporting research projects. In response to this, a consortium of African and
Ebola vaccine candidates are currently being evaluated in phase I–III clinical trials conducted in Africa, the EU and the US. Although preclinical development of candidate vaccines utilise different platforms, including
The way to build bridges instead of walls is still long, but I am happy to have got European Union funding for this project. Africlinique project aims to increase the